Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychotherapy01:28

Psychotherapy

633
Psychotherapy is a versatile, nonmedical approach aimed at helping individuals address emotional, behavioral, and interpersonal issues to enhance their overall well-being. It can involve one-on-one sessions, couples counseling, or small group discussions with a therapist. The therapeutic process includes various techniques such as open discussion, interpretation of thoughts and behaviors, active listening, positive reinforcement, and role modeling. Psychotherapy aims to support individuals in...
633
Psychosurgery01:30

Psychosurgery

2.2K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.2K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

613
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
613
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.

medRxiv : the preprint server for health sciences·2026
Same author

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

Neuro-oncology advances·2026
Same author

CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

Neuro-oncology advances·2026
Same author

Discovery of genetic susceptibility variants in pediatric and adult ependymoma.

Neuro-oncology advances·2026
Same author

The impact of neighborhood-level disadvantage on symptoms, mood, and health-related quality of life among the primary brain tumor population.

Neuro-oncology practice·2026
Same journal

Preface.

Handbook of clinical neurology·2026
Same journal

Foreword.

Handbook of clinical neurology·2026
Same journal

Fundus autofluorescence imaging.

Handbook of clinical neurology·2026
Same journal

The electroretinogram as a means to study the physiology of the retina.

Handbook of clinical neurology·2026
Same journal

Adaptive optics scanning light ophthalmoscopy.

Handbook of clinical neurology·2026
Same journal

Modeling the human retina in a dish: Advances and future directions.

Handbook of clinical neurology·2026
See all related articles

Related Experiment Videos

Psycho-oncology.

Jaap C Reijneveld1, Terri S Armstrong2

  • 1Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.

Handbook of Clinical Neurology
|March 8, 2016
PubMed
Summary
This summary is machine-generated.

Psycho-oncologic care for glioma patients requires balancing treatment decisions for quality of life (QOL) and providing targeted supportive care for debilitating symptoms in patients and caregivers.

Keywords:
caregivercognitionepilepsyfatiguegliomamoodpsycho-oncologyquality of lifesymptoms

Related Experiment Videos

Area of Science:

  • Neuro-oncology
  • Psychological Medicine
  • Quality of Life Research

Background:

  • Psycho-oncologic care is crucial for glioma patients.
  • Balancing treatment benefits with quality of life (QOL) is essential.
  • Supportive care must address symptoms impacting patient and caregiver QOL.

Purpose of the Study:

  • Define and measure QOL in clinical trials for glioma.
  • Analyze the impact of glioma and its treatments on patient QOL.
  • Evaluate symptom management strategies for improving QOL in patients and caregivers.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of QOL measurement tools in clinical trials.
  • Discussion of symptomatic treatment efficacy.

Main Results:

  • QOL is a critical factor in glioma patient care decisions.
  • Glioma and its treatments significantly affect patient and caregiver QOL.
  • Targeted symptom management can improve QOL.

Conclusions:

  • Future research should focus on optimizing psycho-oncologic care for glioma patients.
  • Clinical practice should integrate QOL assessment and symptom management.
  • Caregiver support is integral to holistic glioma patient care.